Pinus densiflora bark extract ameliorates 2,4-dinitrochlorobenzene-induced atopic dermatitis in NC/Nga mice by regulating Th1/Th2 balance and skin barrier function

Phytotherapy Research : PTR
Jun Woo LeeSe-Young Choung

Abstract

Korean red pine (Pinus densiflora) bark has been traditionally used in Korea and other parts of East Asia to relieve inflammatory diseases. Although many studies using P. densiflora bark have been reported, its effect on atopic dermatitis (AD) has not been elucidated. Thus, we investigated whether the P. densiflora bark extract (PBE) has potential to attenuate AD symptoms and elucidated the molecular mechanism. Oral administration of PBE to mice with 2,4-dinitrochlorobenzene (DNCB)-induced AD lessened dermatitis scores and scratching behavior and significantly reduced measures of epidermal thickness, infiltration of mast cells and eosinophils, levels of immunoglobulin E (IgE), and IgG1 /IgG2a ratio in serum. PBE not only inhibited IL-4, IL-5, and IL-13 but also increased IFN-γ in splenic production. Furthermore, PBE significantly suppressed mRNA expression of thymic stromal lymphopoietin and further downregulated the mRNA expression of Th2 and Th17 cytokines such as IL-4, IL-13, IL-17, IL-31, and TNF-α. In addition, the protein expressions of filaggrin, involucrin, and loricrin in lesional skin were recovered by PBE. These results suggest that PBE attenuates DNCB-induced AD via regulating Th1/Th2 balance and skin barrier function.

References

Oct 26, 1999·International Archives of Allergy and Immunology·H SutoC Ra
Aug 5, 2003·The Journal of Allergy and Clinical Immunology·Natalija Novak, Thomas Bieber
Mar 3, 2004·The Journal of Clinical Investigation·Donald Y M LeungQutayba A Hamid
Dec 31, 2005·Journal of the American Academy of Dermatology·Ulrich R HenggeMichael J Cork
Jul 4, 2006·The Journal of Allergy and Clinical Immunology·Bernhard HomeyDonald Y M Leung
Aug 5, 2006·Journal of Dermatological Science·Ehrhardt ProkschJens-Michael Jensen
Aug 11, 2006·Current Allergy and Asthma Reports·Peck Y Ong, Donald Y M Leung
May 22, 2007·The Journal of Allergy and Clinical Immunology·Michael D HowellDonald Y M Leung
Apr 4, 2008·The New England Journal of Medicine·Thomas Bieber
May 15, 2009·Phytotherapy Research : PTR·Yun Ho Choi, Guang Hai Yan
Oct 14, 2011·Journal of Clinical & Cellular Immunology·Eric B Brandt, Umasundari Sivaprasad
Jan 11, 2012·Experimental Dermatology·Danuta Gutowska-OwsiakGraham S Ogg
Apr 18, 2012·Clinics in Dermatology·Ehrhardt Proksch, Jochen Brasch
Jul 27, 2012·The Journal of Investigative Dermatology·Juan Manuel Leyva-CastilloMei Li
Oct 2, 2012·Nature Reviews. Drug Discovery·Pierre Miossec, Jay K Kolls
Oct 15, 2013·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·In-Sik ShinKyung-Seop Ahn
Feb 1, 2014·The Journal of Investigative Dermatology·Saeko NakajimaKenji Kabashima
Jun 26, 2014·The Journal of Pharmacy and Pharmacology·Eun-Hyeong Shim, Se-Young Choung
Jul 17, 2014·The Journal of Investigative Dermatology·Nikhil Dhingra, Emma Guttman-Yassky
Jan 27, 2016·Journal of Nanobiotechnology·Nadezda ShershakovaMusa Khaitov
Oct 25, 2016·Journal of the European Academy of Dermatology and Venereology : JEADV·U NygaardC Vestergaard
Oct 30, 2016·Current Opinion in Immunology·Beatriz Cabanillas, Natalija Novak
Apr 14, 2017·BMJ : British Medical Journal·Akbar K WaljeeBrahmajee K Nallamothu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atopic Dermatitis

Atopic dermatitis is a chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. Discover the latest research on atopic dermatitis here.